RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 1
SP 20
OP 21
DO 10.1177/155989770700700110
UL http://mdc.sagepub.com/content/7/1/20.abstract
AB Ranolazine is an anti-ischemic agent indicated for the treatment of chronic angina. Its effects occur without clinically significant changes in heart rate or blood pressure. However, because ranolazine is associated with a mild prolongation of the QTc interval (mean change approximately 6 ms), it currently is indicated only for patients who have not responded to other therapies. Because of this potentially worrisome prolongation of the QT interval, additional safety data were sought.